These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 6694785

  • 1. Opioid and dopamine involvement in prolactin release induced by arginine vasotocin and vasopressin in the male rat.
    Blask DE, Vaughan MK, Champney TH, Johnson LY, Vaughan GM, Becker RA, Reiter RJ.
    Neuroendocrinology; 1984 Jan; 38(1):56-61. PubMed ID: 6694785
    [Abstract] [Full Text] [Related]

  • 2. Naloxone inhibits arginine vasotocin- (AVT) induced prolactin release in urethane-anesthetized male rats in vivo.
    Blask DE, Vaughan MK.
    Neurosci Lett; 1980 Jun; 18(2):181-4. PubMed ID: 7052489
    [Abstract] [Full Text] [Related]

  • 3. Mediation of the stress-induced prolactin release by hypothalamic histaminergic neurons and the possible involvement of vasopressin in this response.
    Kjaer A, Knigge U, Olsen L, Vilhardt H, Warberg J.
    Endocrinology; 1991 Jan; 128(1):103-10. PubMed ID: 1986913
    [Abstract] [Full Text] [Related]

  • 4. Do the circulating neurohypophysial hormones affect basal or stress induced prolactin (PRL) release in male rats?
    Jurcovicová J, Dobrakovová M, Oprsalová Z, Jezová D, Makara GB, Kvetnanský R.
    Endocr Regul; 1991 Sep; 25(3):159-63. PubMed ID: 1764605
    [Abstract] [Full Text] [Related]

  • 5. Intraventricular administration of arginine vasopressin suppresses prolactin release via a dopaminergic mechanism.
    DePaolo LV, Berardo PV, Carrillo AJ.
    Peptides; 1986 Sep; 7(3):541-4. PubMed ID: 3774591
    [Abstract] [Full Text] [Related]

  • 6. Evidence that opioid peptides and dopamine participate in the suckling-induced release of prolactin in the ewe.
    Knight PG, Howles CM, Cunningham FJ.
    Neuroendocrinology; 1986 Sep; 44(1):29-35. PubMed ID: 3097561
    [Abstract] [Full Text] [Related]

  • 7. Stimulation of rat prolactin secretion in vivo by arginine vasotocin: influence of age of solution, nighttime administration, and dose.
    Vaughan MK, Little JC, Johnson LY, Vaughan GM, Reiter RJ.
    Neuroendocrinology; 1977 Sep; 24(1):35-44. PubMed ID: 600363
    [Abstract] [Full Text] [Related]

  • 8. Involvement of vasopressin in histamine- and stress-induced prolactin release: permissive, mediating or potentiating role?
    Kjaer A, Knigge U, Vilhardt H, Warberg J.
    Neuroendocrinology; 1993 Sep; 57(2):314-21. PubMed ID: 8510805
    [Abstract] [Full Text] [Related]

  • 9. Effects of endogenous opioid peptides and opiates on luteinizing hormone and prolactin secretion in ovariectomized rats.
    Leadem CA, Kalra SP.
    Neuroendocrinology; 1985 Oct; 41(4):342-52. PubMed ID: 4047342
    [Abstract] [Full Text] [Related]

  • 10. Hypothalamic and pituitary sites of action of oxytocin to alter prolactin secretion in the rat.
    Lumpkin MD, Samson WK, McCann SM.
    Endocrinology; 1983 May; 112(5):1711-7. PubMed ID: 6403333
    [Abstract] [Full Text] [Related]

  • 11. Acute effects of arginine vasotocin on plasma and pituitary levels of prolactin in the male rat: influence of urethane anesthesia.
    Johnson LY, Vaughan MK, Reiter RJ, Petterborg LJ, Chen HJ.
    Horm Res; 1980 May; 13(2):109-20. PubMed ID: 6785180
    [Abstract] [Full Text] [Related]

  • 12. Ontogeny of opioid inhibition of vasopressin and oxytocin release in response to osmotic stimulation.
    Hartman RD, Rosella-Dampman LM, Emmert SE, Summy-Long JY.
    Endocrinology; 1986 Jul; 119(1):1-11. PubMed ID: 3720659
    [Abstract] [Full Text] [Related]

  • 13. Effects of melatonin and natural and synthetic analogues of arginine vasotocin on plasma prolactin levels in adult male rats.
    Vaughan MK, Little JC, Johnson LY, Blask DE, Vaughan GM, Reiter RJ.
    Horm Res; 1978 Jul; 9(4):236-46. PubMed ID: 669573
    [Abstract] [Full Text] [Related]

  • 14. Paradoxical effects of oxytocin and vasopressin on basal prolactin secretion and the estrogen-induced prolactin surge.
    Mai LM, Pan JT.
    Life Sci; 1990 Jul; 47(14):1243-51. PubMed ID: 2123015
    [Abstract] [Full Text] [Related]

  • 15. Endogenous opioids mediate the nocturnal prolactin surge in the pregnant rat.
    Sagrillo CA, Voogt JL.
    Endocrinology; 1991 Aug; 129(2):925-30. PubMed ID: 1906806
    [Abstract] [Full Text] [Related]

  • 16. Possible involvement of endogenous opioid peptides in prolactin secretion induced by alpha 2-adrenergic stimulation in rats.
    Koshiyama H, Kato Y, Shimatsu A, Murakami Y, Hattori N, Ishikawa Y, Imura H.
    Proc Soc Exp Biol Med; 1989 Nov; 192(2):105-8. PubMed ID: 2813439
    [Abstract] [Full Text] [Related]

  • 17. Interactions of dopaminergic and peptidergic factors in the control of prolactin release.
    Mogg RJ, Samson WK.
    Endocrinology; 1990 Feb; 126(2):728-35. PubMed ID: 2298169
    [Abstract] [Full Text] [Related]

  • 18. Dermorphin stimulates prolactin secretion in the rat.
    Giudici D, D'Urso R, Falaschi P, Negri L, Melchiorri P, Motta M.
    Neuroendocrinology; 1984 Sep; 39(3):236-44. PubMed ID: 6504268
    [Abstract] [Full Text] [Related]

  • 19. Prolactin-releasing and release-inhibiting factor activities in the bovine, rat, and human pineal gland: in vitro and in vivo studies.
    Blask DE, Vaughan MK, Reiter RJ, Johnson LY, Vaughan GM.
    Endocrinology; 1976 Jul; 99(1):152-62. PubMed ID: 7446
    [Abstract] [Full Text] [Related]

  • 20. Involvement of brain dopamine in prolactin secretion induced by a synthetic Met5-enkephalin analogue in rats.
    Matsushita N, Kato Y, Katakami H, Shimatsu A, Imura H.
    Endocrinol Jpn; 1982 Jun; 29(3):277-85. PubMed ID: 7173110
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.